Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07070115 · ClinicalTrials.gov registry record · NA
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
A NA study of Hiatal Hernia, sponsored by Tela Bio.
- Recruiting
- Registry status
- NA
- Development phase
- 173
- Enrollment target
- 2
- Study locations
NCT07070115 is a NA study of Hiatal Hernia that is actively recruiting participants, run by Tela Bio. The registered enrollment target is 173 participants, below the 871-participant average among 9 other Hiatal Hernia trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT07070115, a NA study of Hiatal Hernia, is actively recruiting participants, sponsored by Tela Bio.
- RECRUITING
- Registry status
- NA
- Development phase
- 173 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will evaluate hiatal hernia recurrence rate and post-operative complications following the use of OviTex Core Resorbable or OviTex 1S Resorbable.
Conditions Studied
Interventions
- DEVICE OviTex Reinforced Tissue Matrix
Study Locations (2)
Alabama
- University of South Alabama Health - Mobile
Texas
- The University of Texas at Austin - Dell Medical School - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2025-07-25 |
| Est. Completion | 2032-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07070115
The ClinicalTrials.gov registry entry for NCT07070115 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 173 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 871-participant average among 9 other Hiatal Hernia trials with a reported enrollment target (80% lower). The listed sponsor is Tela Bio, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hiatal Hernia appearing as the primary indexed condition, and to 1 intervention - of which OviTex Reinforced Tissue Matrix is the first listed.
NCT07070115 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Texas.
Frequently Asked Questions
What is clinical trial NCT07070115 about?
NCT07070115 is a clinical study titled "Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®". This study will evaluate hiatal hernia recurrence rate and post-operative complications following the use of OviTex Core Resorbable or OviTex 1S Resorbable.
What is the current status of trial NCT07070115?
This trial is currently recruiting. It is a NA study. The enrollment target is 173 participants. The study started on 2025-07-25. Estimated completion is 2032-07-31.
What conditions does trial NCT07070115 study?
This clinical trial studies the following conditions: Hiatal Hernia.
What interventions are being tested in trial NCT07070115?
The interventions under investigation include: OviTex Reinforced Tissue Matrix (DEVICE).
Who is sponsoring clinical trial NCT07070115?
This trial is sponsored by Tela Bio, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07070115 being conducted?
This trial has 2 study locations across Alabama, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hiatal Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair
RECRUITING · NA
-
Reducing Postoperative Opioids in Patients Undergoing Laparoscopic Hiatal Hernia
RECRUITING · NA
-
Multicenter Single-Blind RCT of CTIF Versus LNF For Treatment of GERD in Patients Requiring Hiatal Hernia Repair
ACTIVE NOT RECRUITING · NA
-
Esophagogastric Junction Distensibility During Hiatal Hernia Repair
ACTIVE NOT RECRUITING · NA
-
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
COMPLETED · NA
-
Miromatrix Biological Mesh for Hiatal Hernia Repair
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.